US gives Edwards conditional OK for percutaneous heart valve trial
This article was originally published in Clinica
Executive Summary
Bringing minimally invasive heart valve replacement a step closer, Edwards Lifesciences has received conditional approval from the US FDA to begin a feasibility trial of its Cribier-Edwards percutaneous aortic heart valve.